Back to Search
ELIZABETH HEATH, B.S., PHARMD
B.S., PHARMD
Pharmacist
NPI: 1457772527Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
23833(NC)
Research & Publications (20)
A complex investigation of the extent of pollution in sediments of the Sava River: part 2: persistent organic pollutants.
PMID 19259775·Environ Monit Assess·2010
8-other
Theoretical and practical application of traditional and accelerated titration Phase I clinical trial designs: the Wayne State University experience.
PMID 19384685·J Biopharm Stat·2009
8-other
A phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with hormone-refractory metastatic prostate cancer.
PMID 19047126·Clin Cancer Res·2008
3-trial
The effect of race/ethnicity on the accuracy of the 2001 Partin Tables for predicting pathologic stage of localized prostate cancer.
PMID 18242385·Urology·2008
4-observational
A phase 1 study of SNS-032 (formerly BMS-387032), a potent inhibitor of cyclin-dependent kinases 2, 7 and 9 administered as a single oral dose and weekly infusion in patients with metastatic refractory solid tumors.
PMID 17938863·Invest New Drugs·2008
3-trial
Secondary chemoprevention of Barrett's esophagus with celecoxib: results of a randomized trial.
PMID 17405999·J Natl Cancer Inst·2007
3-trial
New targets in the management of prostate cancer.
PMID 16861127·Hematol Oncol Clin North Am·2006
6-review
Phase II, parallel-design study of preoperative combined modality therapy and the matrix metalloprotease (mmp) inhibitor prinomastat in patients with esophageal adenocarcinoma.
PMID 16502351·Invest New Drugs·2006
3-trial
Biodegradation of chlorinated alkanes and their commercial mixtures by Pseudomonas sp. strain 273.
PMID 16491365·J Ind Microbiol Biotechnol·2006
8-other
A phase II trial of 17-allylamino-17- demethoxygeldanamycin in patients with hormone-refractory metastatic prostate cancer.
PMID 16197617·Clin Prostate Cancer·2005
8-other
Chemoprevention for Barrett's esophagus trial. Design and outcome measures.
PMID 14641306·Dis Esophagus·2003
3-trial
The design of a randomized, placebo-controlled trial of celecoxib in preprostatectomy men with clinically localized adenocarcinoma of the prostate.
PMID 15046694·Clin Prostate Cancer·2002
8-other
Phase II trial of docetaxel chemotherapy in patients with incurable adenocarcinoma of the esophagus.
PMID 12003198·Invest New Drugs·2002
3-trial
Phase I trial of the matrix metalloproteinase inhibitor BAY12-9566 in patients with advanced solid tumors.
PMID 11710626·Cancer Chemother Pharmacol·2001
3-trial
Use of buccal cells collected in mouthwash as a source of DNA for clinical testing.
PMID 11151066·Arch Pathol Lab Med·2001
8-other
The role of laparoscopy in preoperative staging of esophageal cancer.
PMID 10858480·Surg Endosc·2000
8-other
Clinical potential of matrix metalloprotease inhibitors in cancer therapy.
PMID 10852638·Drugs·2000
6-review
Adenocarcinoma of the esophagus: risk factors and prevention.
PMID 10826312·Oncology (Williston Park)·2000
6-review
Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus.
PMID 10673530·J Clin Oncol·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 412 CAPTAINS CV UNIT B
EDENTON, NC 27932 - Phone
- (252) 775-0414
Quick Facts
- NPI
- 1457772527
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile